475 related articles for article (PubMed ID: 17140960)
21. Total number of resected lymph nodes predicts survival in esophageal cancer.
Altorki NK; Zhou XK; Stiles B; Port JL; Paul S; Lee PC; Mazumdar M
Ann Surg; 2008 Aug; 248(2):221-6. PubMed ID: 18650631
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status.
Eloubeidi MA; Desmond R; Arguedas MR; Reed CE; Wilcox CM
Cancer; 2002 Oct; 95(7):1434-43. PubMed ID: 12237911
[TBL] [Abstract][Full Text] [Related]
23. [Clinical implications of the new TNM staging system for thoracic esophageal squamous cell carcinoma].
Fang WT; Feng J; Mao T; Fu SJ; Chen WH
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):687-91. PubMed ID: 22340051
[TBL] [Abstract][Full Text] [Related]
24. Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes.
Peyre CG; Hagen JA; DeMeester SR; Van Lanschot JJ; Hölscher A; Law S; Ruol A; Ancona E; Griffin SM; Altorki NK; Rice TW; Wong J; Lerut T; DeMeester TR
Ann Surg; 2008 Dec; 248(6):979-85. PubMed ID: 19092342
[TBL] [Abstract][Full Text] [Related]
25. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
Steven K; Poulsen AL
J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
[TBL] [Abstract][Full Text] [Related]
26. Lymph node ratio is a significant predictor of disease-specific mortality in patients undergoing esophagectomy for cancer.
Fox M; Farmer R; Scoggins CR; McMasters KM; Martin RC
Am Surg; 2012 May; 78(5):528-34. PubMed ID: 22546123
[TBL] [Abstract][Full Text] [Related]
27. [The patterns and prognostic factors of abdominal lymph node metastasis in patients with the middle thoracic esophageal squamous cell carcinoma].
Wang Z; Liu XY; Liu FY
Zhonghua Wai Ke Za Zhi; 2008 Dec; 46(23):1800-3. PubMed ID: 19094790
[TBL] [Abstract][Full Text] [Related]
28. Appraisal of a revised lymph node classification system for esophageal squamous cell cancer.
Dhar DK; Hattori S; Tonomoto Y; Shimoda T; Kato H; Tachibana M; Matsuura K; Mitsumoto Y; Little AG; Nagasue N
Ann Thorac Surg; 2007 Apr; 83(4):1265-72. PubMed ID: 17383324
[TBL] [Abstract][Full Text] [Related]
29. An evaluation of the number of lymph nodes examined and survival for node-negative esophageal carcinoma: data from China.
Yang HX; Xu Y; Fu JH; Wang JY; Lin P; Rong TH
Ann Surg Oncol; 2010 Jul; 17(7):1901-11. PubMed ID: 20146101
[TBL] [Abstract][Full Text] [Related]
30. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
Zhang X; Watson DI; Jamieson GG
Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the 6th and 7th editions of the American Joint Committee on Cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma.
Hsu PK; Wu YC; Chou TY; Huang CS; Hsu WH
Ann Thorac Surg; 2010 Apr; 89(4):1024-31. PubMed ID: 20338302
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients.
Tachibana M; Hirahara N; Kinugasa S; Yoshimura H
Ann Surg Oncol; 2008 Jan; 15(1):104-16. PubMed ID: 17891442
[TBL] [Abstract][Full Text] [Related]
33. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial.
Omloo JM; Lagarde SM; Hulscher JB; Reitsma JB; Fockens P; van Dekken H; Ten Kate FJ; Obertop H; Tilanus HW; van Lanschot JJ
Ann Surg; 2007 Dec; 246(6):992-1000; discussion 1000-1. PubMed ID: 18043101
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic evaluation of lymph node metastasis in thoracic esophageal cancer--an analysis of 212 cases].
Chen JH; Wei GQ; Chen MY
Zhonghua Zhong Liu Za Zhi; 1994 Nov; 16(6):441-3. PubMed ID: 7720501
[TBL] [Abstract][Full Text] [Related]
35. Prediction of lymph node status in superficial esophageal carcinoma.
Ancona E; Rampado S; Cassaro M; Battaglia G; Ruol A; Castoro C; Portale G; Cavallin F; Rugge M
Ann Surg Oncol; 2008 Nov; 15(11):3278-88. PubMed ID: 18726651
[TBL] [Abstract][Full Text] [Related]
36. The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma.
Kuru B; Bozgul M
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1328-34. PubMed ID: 16997505
[TBL] [Abstract][Full Text] [Related]
37. En bloc vs transhiatal esophagectomy for stage T3 N1 adenocarcinoma of the distal esophagus.
Johansson J; DeMeester TR; Hagen JA; DeMeester SR; Peters JH; Oberg S; Bremner CG
Arch Surg; 2004 Jun; 139(6):627-31; discussion 631-3. PubMed ID: 15197089
[TBL] [Abstract][Full Text] [Related]
38. Developing an appropriate staging system for esophageal carcinoma.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
J Am Coll Surg; 2005 Dec; 201(6):884-90. PubMed ID: 16310691
[TBL] [Abstract][Full Text] [Related]
39. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma.
Pedrazzani C; de Manzoni G; Marrelli D; Giacopuzzi S; Corso G; Minicozzi AM; Rampone B; Roviello F
J Thorac Cardiovasc Surg; 2007 Aug; 134(2):378-85. PubMed ID: 17662776
[TBL] [Abstract][Full Text] [Related]
40. [Impact of number and extent of lymph node metastasis on prognosis of thoracic esophageal cancer].
FENG J; MAO T; CHEN WH; FANG WT
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Sep; 14(9):715-8. PubMed ID: 21948541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
